Carina Wattmo

Summary

Affiliation: Lund University
Country: Sweden

Publications

  1. ncbi Prediction models for assessing long-term outcome in Alzheimer's disease: a review
    Carina Wattmo
    Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden
    Am J Alzheimers Dis Other Demen 28:440-9. 2013
  2. pmc A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy
    Carina Wattmo
    Clinical Memory Research Unit, Department of Clinical Sciences, Malmo, Lund University, Malmo, Sweden
    Clin Interv Aging 8:329-39. 2013
  3. pmc Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort
    Carina Wattmo
    Clinical Memory Research Unit, Department of Clinical Sciences, Malmo, Lund University, Malmo, Sweden
    BMC Neurol 12:134. 2012
  4. pmc Predictors of long-term cognitive outcome in Alzheimer's disease
    Carina Wattmo
    Clinical Memory Research Unit, Department of Clinical Sciences, Malmo, Lund University, SE 205 02 Malmo, Sweden
    Alzheimers Res Ther 3:23. 2011
  5. ncbi Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment
    Carina Wattmo
    Department of Clinical Sciences, Clinical Memory Research Unit, Malmo, Lund University, Sweden
    Alzheimer Dis Assoc Disord 25:63-72. 2011
  6. ncbi Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment
    Carina Wattmo
    Department of Neuropsychiatry, Skane University Hospital, SE 205 02 Malmo, Sweden
    Gerontologist 51:17-27. 2011
  7. ncbi Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting
    Carina Wattmo
    Clinical Memory Research Unit, Department of Clinical Sciences, Malmo, Lund University, Malmo, Sweden
    Dement Geriatr Cogn Disord 26:203-11. 2008
  8. ncbi Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting
    Asa K Wallin
    Clinical Memory Research Unit, Department of Clinical Sciences, Malmo, Lund University, Malmo, Sweden
    Dement Geriatr Cogn Disord 23:150-60. 2007
  9. pmc Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study
    Sebastian Palmqvist
    Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmo, Sweden
    PLoS ONE 7:e38639. 2012
  10. ncbi Association between subcortical lesions and behavioral and psychological symptoms in patients with Alzheimer's disease
    Sebastian Palmqvist
    Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmo, Sweden
    Dement Geriatr Cogn Disord 32:417-23. 2011

Detail Information

Publications17

  1. ncbi Prediction models for assessing long-term outcome in Alzheimer's disease: a review
    Carina Wattmo
    Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden
    Am J Alzheimers Dis Other Demen 28:440-9. 2013
    ..More sophisticated models that also accommodate patient-specific characteristics should be developed for comparisons in future long-term AD studies. ..
  2. pmc A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy
    Carina Wattmo
    Clinical Memory Research Unit, Department of Clinical Sciences, Malmo, Lund University, Malmo, Sweden
    Clin Interv Aging 8:329-39. 2013
    ..To investigate the long-term effects of cholinesterase inhibitor (ChEI) therapy and the influence of sociodemographic and clinical factors on the use of community-based home help services (HHS) by patients with Alzheimer's disease (AD)...
  3. pmc Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort
    Carina Wattmo
    Clinical Memory Research Unit, Department of Clinical Sciences, Malmo, Lund University, Malmo, Sweden
    BMC Neurol 12:134. 2012
    ..The aim of this study was to identify the socio-demographic and clinical factors that affect the functional response after 6 months of ChEI therapy...
  4. pmc Predictors of long-term cognitive outcome in Alzheimer's disease
    Carina Wattmo
    Clinical Memory Research Unit, Department of Clinical Sciences, Malmo, Lund University, SE 205 02 Malmo, Sweden
    Alzheimers Res Ther 3:23. 2011
    ..The objective of this study was to describe the longitudinal cognitive outcome in Alzheimer's disease (AD) and analyze factors that affect the outcome, including the impact of different cholinesterase inhibitors (ChEI)...
  5. ncbi Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment
    Carina Wattmo
    Department of Clinical Sciences, Clinical Memory Research Unit, Malmo, Lund University, Sweden
    Alzheimer Dis Assoc Disord 25:63-72. 2011
    ..AD severity at baseline is a key factor in obtaining reliable clinical prognoses of the long-term ADL ability. The dosage of ChEI treatment could possibly lead to a different functional outcome...
  6. ncbi Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment
    Carina Wattmo
    Department of Neuropsychiatry, Skane University Hospital, SE 205 02 Malmo, Sweden
    Gerontologist 51:17-27. 2011
    ....
  7. ncbi Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting
    Carina Wattmo
    Clinical Memory Research Unit, Department of Clinical Sciences, Malmo, Lund University, Malmo, Sweden
    Dement Geriatr Cogn Disord 26:203-11. 2008
    ....
  8. ncbi Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting
    Asa K Wallin
    Clinical Memory Research Unit, Department of Clinical Sciences, Malmo, Lund University, Malmo, Sweden
    Dement Geriatr Cogn Disord 23:150-60. 2007
    ..Clinical short-term trails have shown positive effects of donepezil treatment in patients with Alzheimer's disease. The outcome of continuous long-term treatment in the routine clinical settings remains to be investigated...
  9. pmc Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study
    Sebastian Palmqvist
    Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmo, Sweden
    PLoS ONE 7:e38639. 2012
    ..In this study, we compared brief cognitive tests and cerebrospinal fluid (CSF) biomarkers in predicting conversion from mild cognitive impairment (MCI) to AD...
  10. ncbi Association between subcortical lesions and behavioral and psychological symptoms in patients with Alzheimer's disease
    Sebastian Palmqvist
    Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmo, Sweden
    Dement Geriatr Cogn Disord 32:417-23. 2011
    ..There is controversy as to whether subcortical lesions contribute to BPSD. The aim of this study was to examine the relationship between BPSD and subcortical lesions (white-matter lesions and lacunes) in AD...
  11. ncbi Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia
    Victoria Larsson
    Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmo, Sweden
    Dement Geriatr Cogn Disord 32:227-34. 2011
    ..To investigate quality of life (QOL) and the effect of memantine treatment in patients with Lewy body dementias...
  12. ncbi Risk factors that affect life expectancy in Alzheimer's disease: a 15-year follow-up
    Carina Wattmo
    Clinical Memory Research Unit, Department of Clinical Sciences, Malmo, Lund University, Malmo, Sweden
    Dement Geriatr Cogn Disord 38:286-99. 2014
    ..Future disease-modifying therapies might affect the expected life span in Alzheimer's disease (AD). Our aim was to identify factors that influence life expectancy in cholinesterase inhibitor (ChEI)-treated patients...
  13. ncbi Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services
    Carina Wattmo
    Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden
    Clin Interv Aging 9:1951-62. 2014
    ..This study aimed to describe the cognitive and functional abilities of solitary-living AD patients, and the potential predictors of their usage of community-based services...
  14. pmc A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease
    Sebastian Palmqvist
    Clinical Memory Research Unit, Department of Clinical Sciences Malmo, Lund University, S 205 02 Malmo, Sweden
    Alzheimers Res Ther 2:29. 2010
    ..In this study, A Quick Test of cognitive speed (AQT) was compared with the mini-mental state examination (MMSE) in the evaluation of treatment outcome in AD...
  15. pmc Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting
    Asa K Wallin
    Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmo, Sweden
    Neuropsychiatr Dis Treat 7:565-76. 2011
    ..This study aimed to explore the three-year effects of galantamine treatment, as well as subgroups of response and adherence to treatment...